We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Stored Blood for Transfusion Is Practical After Heart Surgery

By LabMedica International staff writers
Posted on 01 Nov 2015
Print article
Image: Blood transfusion bags containing different blood types (Photo courtesy of Terinah DoBa).
Image: Blood transfusion bags containing different blood types (Photo courtesy of Terinah DoBa).
Patients often need transfusions of red blood cells to replace the blood they have lost during major surgeries, however, the question of whether stored blood is safe for heart surgery patients has had mixed answers.

Red blood cells (RBCs) or erythrocytes that transport oxygen throughout the body go through several changes while in storage, potentially decreasing their oxygen-carrying ability and until now, it has not been clear as to whether such changes affect patient outcome after receiving transfusions.

Clinical scientists at the Karolinska University Hospital (Stockholm, Sweden) identified all patients who underwent coronary artery bypass graft surgery, heart valve surgery, or both between 1997 and 2012. Transfusion data were obtained from the nationwide register of blood transfusions database. Storage of RBCs was classified with discrete patient groups who had exclusively received blood stored less than 14 days, 14 to 27 days, or 28 to 42 days, and a mixed storage category for patients receiving blood of mixed age. Follow-up was completed on December 31, 2013.

Between 1997 and 2012, 47,071 patients were transfused in connection with cardiac surgery in nine Swedish hospitals. Women constituted 39.2% and the mean ±SD age was 70.0 ±9.7 years. Of these patients, 36.6% exclusively received RBCs stored less than 14 days; 26.8%, RBCs stored 14 to 27 days; 8.9%, RBCs stored 28 to 42 days; and 27.8%, RBCs of mixed age. Most clinical parameters were similar in the groups, although the less common blood groups such as AB and B, were more common with longer storage. Recipients of the freshest blood received more transfusions, 3.1 versus 2. No differences were observed for a range of comorbidities. After investigating patient outcomes, the team found that the use of stored blood units did not influence heart surgery patient outcomes.

Ulrik Sartipy, MD, PhD, the lead author of the study said, “This study is by far the largest investigation focusing on the issue of blood storage in this very sensitive patient group, and we find absolutely no hint of negative health effects associated with stored blood.” The study provides very firm reassurance that the current blood storage practices are safe. The study was published on October 20, 2015, in the Journal of the American Medical Association (JAMA).

Related Links:

Karolinska University Hospital


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.